Table 1.
Patient and donor characteristics broken down by three time periods of COVID-19 activity in 2020
| N | Early Jan 1–Mar 15 | Middle Mar 15–Apr 30 | Late May 1–Jun 30 | p value |
|---|---|---|---|---|
| 122 | 36 | 121 | ||
| Recipient factors | ||||
| Wait time (IQR) | 202.5 (81, 618) | 201.5 (42.5, 547) | 227 (92, 495) | 0.87 |
| Female Sex | 59 (48.4%) | 14 (38.9%) | 56 (46.3%) | 0.61 |
| Race | 0.28 | |||
| White | 95 (77.9%) | 21 (58.3%) | 86 (71.1%) | |
| Black | 16 (13.1%) | 11 (30.6%) | 25 (20.7%) | |
| Asian | 7 (5.7%) | 3 (8.3%) | 8 (6.6%) | |
| Others | 4 (3.3%) | 1 (2.8%) | 2 (1.7%) | |
| ABO Blood Type | 0.94 | |||
| Type O | 70 (57.4%) | 21 (58.3%) | 71 (58.7%) | |
| Type A | 30 (24.6%) | 10 (27.8%) | 34 (28.1%) | |
| Type B | 16 (13.1%) | 4 (11.1%) | 13 (10.7%) | |
| Type AB | 6 (4.9%) | 1 (2.8%) | 3 (2.5%) | |
| Primary diagnosis | 0.065 | |||
| Glomerulonephritis | 21 (17.2%) | 2 (5.6%) | 17 (14.0%) | |
| FSGS | 15 (12.3%) | 5 (13.9%) | 15 (12.4%) | |
| Hypoplasia | 32 (26.2%) | 7 (19.4%) | 14 (11.6%) | |
| Obstructive | 19 (15.6%) | 8 (22.2%) | 19 (15.7%) | |
| Polycystic | 9 (7.4%) | 2 (5.6%) | 18 (14.9%) | |
| Others | 26 (21.3%) | 12 (33.3%) | 38 (31.4%) | |
| cPRA, mean (SD) | 12% (24) | 9% (26) | 7% (20) | 0.29 |
| cPRA ≠ 0, median (IQR) | 44% (5, 64) (n = 36) | 61% (5, 99) (n = 7) | 11% (0, 52) (n = 31) | 0.087 |
| cPRA ≥ 0.2 | 23 (18.9%) | 4 (11.1%) | 15 (12.4%) | 0.33 |
| Donor factors | ||||
| Age (year), median (IQR) | 28 (20, 34) | 25.50 (21.50, 32) | 28 (22, 35) | 0.68 |
| Female gender | 52 (42.6%) | 16 (44.4%) | 51 (42.1%) | 0.97 |
| Living donor | 36 (29.5%) | 5 (13.9%) | 44 (36.4%) | 0.035* |
| Race | 0.55 | |||
| White | 103 (84.4%) | 29 (80.6%) | 102 (84.3%) | |
| Black | 13 (10.7%) | 3 (8.3%) | 15 (12.4%) | |
| Asian | 3 (2.5%) | 3 (8.3%) | 3 (2.5%) | |
| Other race | 3 (2.5%) | 1 (2.8%) | 1 (0.8%) | |
| KDPI | n = 86 | n = 31 | n = 77 | |
| Median (IQR) | 13.73 (7.65, 26.72) | 14.57 (5.93, 28.99) | 17.56 (9.71, 28.34) | 0.46 |
| Mean (SD) | 17.30 (13.46) | 17.38 (12.63) | 19.21 (12.18) | 0.61 |
| Cold ischemic time (hours), median (IQR) | 9.0 (4.0, 13.2) (n = 121) | 10.2 (6.5, 17.5) (n = 34) | 7.6 (2.4, 10.7) (n = 57) | 0.021* |
IQR interquartile range, FSGS focal segmental glomerulosclerosis, cPRA calculated panel-reactive antibody, SD standard deviation, KDPI kidney donor profile index
*p < 0.05